Daniel is a European patent attorney with great technical skills. He has a First-class degree in Biochemistry from the University of Leeds, which included a one-year placement at GlaxoSmithKline, and a doctorate from the University of Oxford, where he studied innate immune signal transduction pathways in infection and cancer.

Daniel has worked with a wide range of businesses, from start-ups through to multinational corporations. Daniel specialises in the Life Sciences, covering inventions from the biotechnology, immunology, oncology, molecular biology, biomarkers, gene therapy, diagnostics and vaccine fields. He has experience across many areas of patent work including the filing and prosecution of UK, European and overseas applications as well as advising on freedom-to-operate (FTO) and infringement matters.


  • Completed research experience at a global pharmaceutical enterprise, smaller biotech company and academia
  • Awarded an MRC-funded studentship to complete doctoral studies at the University of Oxford based on a research proposal made
  • Placement at Domantis helping to develop novel therapeutics for the treatment of Hepatitis C
  • Has helped prosecute multiple applications to grant, finding ways through complex prior art
  • Provided a comprehensive infringement opinion to a client on a commercially important product


“Daniel Gaughan has provided outstanding expertise, which has successfully influenced the progression of our patent application.  Always professional, conscientious and technically skilled, Daniel has been a pleasure to work with.”

Professor Graham Ogg, Professor of Dermatology, University of Oxford.


“It has been a pleasure to work with Daniel Gaughan at Barker Brettell. He has worked on numerous patent applications with us and has shown very good understanding and knowledge of the underlying science and a quick grasp of new concepts. His patent drafts have been well prepared and he has been responsive and constructive in making adjustments, even when deadlines are looming.”

Professor Sir Andrew McMichael FRS, University of Oxford.